Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
13 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Capecitabine Medac“
Suchtreffer
Begriffe & Kennungen
Capecitabine Medac · 4.8 · HFS (see section 4.4) For the capecitabine dose of 1,250 mg/m² twice daily on days 1 to 14 every 3 weeks, a fr
Eintrag öffnenCapecitabine Medac · 4.8 · Patients with renal impairment (see section 4.2, 4.4, and 5.2) An analysis of safety data in patients treated
Eintrag öffnenCapecitabine Medac · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenCapecitabine Medac · 4.8 · Some of the ADRs are reactions commonly seen with the combination medicinal product (e.g. peripheral sensory n
Eintrag öffnenCapecitabine Medac · 4.8 · Special populations
Eintrag öffnenCapecitabine Medac · 4.8 · Summary of the safety profile
Eintrag öffnenCapecitabine Medac · 4.8 · Table 4 Summary of related ADRs reported in patients treated with capecitabine monotherapy Body system Very Co
Eintrag öffnenCapecitabine Medac · 4.8 · Table 5 Summary of related ADRs reported in patients treated with capecitabine in combination treatment in add
Eintrag öffnenCapecitabine Medac · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenCapecitabine Medac · 4.8 · The most commonly reported and/or clinically relevant treatment-related ADRs were gastrointestinal disorders (
Eintrag öffnenCapecitabine Medac · 4.8 · The overall safety profile of capecitabine is based on data from over 3,000 patients treated with capecitabine
Eintrag öffnenCapecitabine Medac · 4.8 · The results of a meta-analysis of 14 clinical trials with data from over 4,700 patients treated with capecitab
Eintrag öffnenCapecitabine Medac · 4.8 · The results of a meta-analysis of 14 clinical trials with data from over 4,700 patients treated with capecitab
Eintrag öffnen